908 Devices Inc. filings document an operating company that sells common stock under MASS on the Nasdaq Global Market and reports on handheld chemical analysis tools used in health, safety and defense technology markets. Form 8-K reports furnish operating and financial results, revenue outlook materials, material-event disclosures, material agreements, capital-structure matters and related exhibits.
Proxy materials cover annual meeting voting matters, including director elections, auditor ratification, executive compensation votes and the frequency of future advisory compensation votes. The filing record also includes governance disclosures tied to board composition, annual meeting procedures, shareholder voting mechanics and emerging growth company status.
908 Devices Inc. reported fourth-quarter and full-year 2025 results and provided a 2026 revenue outlook. Q4 2025 revenue was $17.4 million, up 21% year over year, and net income from continuing operations reached $4.4 million, with positive Adjusted EBITDA of $0.7 million.
For 2025, revenue from continuing operations was $56.2 million, an 18% increase, while net loss from continuing operations narrowed to $33.3 million. Net income attributable to common stockholders was $19.5 million, helped by discontinued operations, and cash, cash equivalents and marketable securities totaled $113.0 million with no debt.
The company expects 2026 revenue between $64.5 million and $67.5 million, representing 15% to 20% growth over 2025 revenue from continuing operations.
First Light Asset Management, LLC and Mathew P. Arens have disclosed significant passive ownership stakes in 908 Devices Inc. First Light reports beneficial ownership of 5,964,739 common shares, representing 16.48% of the company. Arens reports beneficial ownership of 6,184,739 shares, or 17.09% of the class.
The filing explains that First Light holds shares as an investment adviser to separately managed accounts and private funds, while Arens controls First Light and also owns additional shares directly and in joint accounts. They certify the holdings are in the ordinary course of business and not for the purpose of influencing control of 908 Devices.
State Street Corporation has reported beneficial ownership of 596,294 shares of 908 Devices Inc common stock, representing 1.6% of the class as of 12/31/2025. These shares are held with shared voting power over 564,044 shares and shared dispositive power over 596,294 shares.
Through subsidiary SSGA Funds Management, Inc., the group reports beneficial ownership of 134,786 shares, or 0.4% of the class, all with shared voting and dispositive power. The securities are certified as held in the ordinary course of business, not for the purpose of changing or influencing control of 908 Devices.
908 Devices Inc. director Christopher D. Brown reported the settlement of three batches of restricted stock units (RSUs) into Common Stock on February 1, 2026. RSUs covering 5,027, 7,418, and 10,992 shares converted into the same number of Common shares at an exercise price of $0 per share.
Following these vesting events, Brown directly beneficially owns 985,559 shares of Common Stock and 21,982 RSUs. The RSU awards vest in four substantially equal annual installments on anniversary dates following February 1, 2022, February 1, 2023, and February 1, 2024, subject to his continued service.
908 Devices Inc. President and CEO Kevin J. Knopp reported equity compensation activity and a tax-related share sale. On February 1, 2026, several Restricted Stock Units vested and were settled for 11,255, 13,449, 17,007, and 66,288 shares of common stock, increasing his direct holdings to 830,732 shares.
On February 2, 2026, Knopp sold 34,764 shares of common stock at a weighted average price of $6.18 solely to cover tax withholding from the RSU vesting, leaving 795,968 shares held directly. He also received 205,978 new RSUs and a stock option for 90,043 shares at a $6.19 exercise price, which begin vesting on February 1, 2027. Separately, 541,223 shares are held indirectly by The Kevin J. Knopp Irrevocable Trust of 2018, for which his brother-in-law serves as trustee with sole voting and dispositive control.
908 Devices Inc. Chief Financial Officer Joseph H. Griffith IV reported a mix of equity grants, vesting and a tax-related sale. On February 1, 2026, several tranches of RSUs vested and settled into 5,102, 10,306, 11,260 and 43,473 shares of common stock. On February 2, 2026, he received 121,164 new RSUs and a stock option for 52,967 shares with a $6.19 exercise price. That same day, he sold 23,175 shares at a weighted average of $6.18 solely to cover tax withholding triggered by the RSU vesting, under a required “sell to cover” arrangement. After these transactions, he directly held 139,896 shares of common stock.
Director Mark Spoto of 908 Devices Inc. reported family-related movements of common stock. On 10/14/2025, 928 shares were acquired at $0 and held indirectly through his spouse. On 12/30/2025, 928 shares were reported as a gift from his spouse, leaving 928 shares no longer held indirectly and 928 shares counted as directly owned, with a total of 75,263 common shares shown as directly held afterward. The filing also shows 3,599 common shares held indirectly through Razor's Edge Ventures, LLC, an entity where Spoto is a managing member and for which he disclaims beneficial ownership beyond his pecuniary interest.
908 Devices Inc. furnished a Form 8-K to report that it has announced preliminary financial results for the fourth quarter and fiscal year ended December 31, 2025. The company issued a press release on January 20, 2026 describing these preliminary results, which is included as Exhibit 99.1.
The information about results of operations and financial condition is being furnished under Item 2.02 of the Form 8-K and is not considered filed for purposes of certain liability provisions of the federal securities laws, unless specifically incorporated by reference in other filings.
908 Devices Inc. (MASS) reported Q3 2025 results. Revenue was $14.0 million, slightly below $14.5 million a year ago, while year-to-date revenue rose to $38.8 million from $33.4 million. Gross profit for the quarter was $7.4 million.
Operating expenses reflected a $10.7 million increase in the fair value of contingent consideration, driving a Q3 loss from continuing operations of $14.9 million. Year-to-date loss from continuing operations was $37.7 million.
The company completed the sale of its Desktop Portfolio to Repligen, recording a $56.1 million gain within discontinued operations. As a result, year-to-date net income attributable to common stockholders was $15.3 million.
Liquidity strengthened with cash and cash equivalents of $62.8 million and marketable securities of $49.3 million at September 30, 2025. Deferred revenue was $18.3 million. A current contingent consideration liability of $23.0 million reflects updated fair value tied to prior acquisitions.
Shares outstanding were 36,118,576 at September 30, 2025; as of November 5, 2025, they were 36,192,978.
908 Devices Inc. (MASS) furnished a press release announcing its financial results for the third quarter ended September 30, 2025. The release is attached as Exhibit 99.1 to a Form 8-K dated November 10, 2025.
The information under Item 2.02 is being furnished, not filed, under the Exchange Act. MASS’s common stock trades on The NASDAQ Global Market.